11.15 Resource AdministrableProductDefinition - Content

<AdministrableProductDefinition xmlns="http://hl7.org/fhir"> 
 <!-- from Resource: id, meta, implicitRules, and language -->
 <!-- from DomainResource: text, contained, extension, and modifierExtension -->
 <identifier><!-- 0..* Identifier An identifier for the pharmaceutical medicinal product --></identifier>
 <subject><!-- 0..* Reference(MedicinalProductDefinition) The product that this is a pharmaceutical product of --></subject>
 <administrableDoseForm><!-- 1..1 CodeableConcept The administrable dose form, after necessary reconstitution --></administrableDoseForm>
 <unitOfPresentation><!-- 0..1 CodeableConcept Todo --></unitOfPresentation>
 <producedFrom><!-- 0..* Reference(ManufacturedItemDefinition) The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients --></producedFrom>
 <ingredient><!-- 0..* Reference(Ingredient) The ingredients of this administrable pharmaceutical product --></ingredient>
 <device><!-- 0..* Reference(DeviceDefinition) Accompanying device --></device>
 <characteristic>  <!-- 0..* Characteristics e.g. a products onset of action -->
  <code><!-- 1..1 CodeableConcept A code expressing the type of characteristic --></code>
  <value[x]><!-- 0..1 Coding|Quantity|string|date|boolean|Attachment A value for the characteristic --></value[x]>
  <status><!-- 0..1 CodeableConcept The status of characteristic e.g. assigned or pending --></status>
 </characteristic>
 <routeOfAdministration>  <!-- 1..* The path by which the pharmaceutical product is taken into or makes contact with the body -->
  <code><!-- 1..1 CodeableConcept Coded expression for the route --></code>
  <firstDose><!-- 0..1 Quantity The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement --></firstDose>
  <maxSingleDose><!-- 0..1 Quantity The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement --></maxSingleDose>
  <maxDosePerDay><!-- 0..1 Quantity The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerDay>
  <maxDosePerTreatmentPeriod><!-- 0..1 Ratio The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerTreatmentPeriod>
  <maxTreatmentPeriod><!-- 0..1 Duration The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation --></maxTreatmentPeriod>
  <targetSpecies>  <!-- 0..* A species for which this route applies -->
   <code><!-- 1..1 CodeableConcept Coded expression for the species --></code>
   <withdrawalPeriod>  <!-- 0..* A species specific time during which consumption of animal product is not appropriate -->
    <tissue><!-- 1..1 CodeableConcept Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk --></tissue>
    <value><!-- 1..1 Quantity A value for the time --></value>
    <supportingInformation value="[string]"/><!-- 0..1 Extra information about the withdrawal period -->
   </withdrawalPeriod>
  </targetSpecies>
 </routeOfAdministration>
</AdministrableProductDefinition>

{
  "resourceType" : "AdministrableProductDefinition",
  // from Resource: id, meta, implicitRules, and language
  // from DomainResource: text, contained, extension, and modifierExtension
  "identifier" : [{ Identifier }], // An identifier for the pharmaceutical medicinal product
  "subject" : [{ Reference(MedicinalProductDefinition) }], // The product that this is a pharmaceutical product of
  "administrableDoseForm" : { CodeableConcept }, // R!  The administrable dose form, after necessary reconstitution
  "unitOfPresentation" : { CodeableConcept }, // Todo
  "producedFrom" : [{ Reference(ManufacturedItemDefinition) }], // The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients
  "ingredient" : [{ Reference(Ingredient) }], // The ingredients of this administrable pharmaceutical product
  "device" : [{ Reference(DeviceDefinition) }], // Accompanying device
  "characteristic" : [{ // Characteristics e.g. a products onset of action
    "code" : { CodeableConcept }, // R!  A code expressing the type of characteristic
    // value[x]: A value for the characteristic. One of these 6:
    "valueCoding" : { Coding },
    "valueQuantity" : { Quantity },
    "valueString" : "<string>",
    "valueDate" : "<date>",
    "valueBoolean" : <boolean>,
    "valueAttachment" : { Attachment },
    "status" : { CodeableConcept } // The status of characteristic e.g. assigned or pending
  }],
  "routeOfAdministration" : [{ // R!  The path by which the pharmaceutical product is taken into or makes contact with the body
    "code" : { CodeableConcept }, // R!  Coded expression for the route
    "firstDose" : { Quantity }, // The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
    "maxSingleDose" : { Quantity }, // The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
    "maxDosePerDay" : { Quantity }, // The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
    "maxDosePerTreatmentPeriod" : { Ratio }, // The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
    "maxTreatmentPeriod" : { Duration }, // The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
    "targetSpecies" : [{ // A species for which this route applies
      "code" : { CodeableConcept }, // R!  Coded expression for the species
      "withdrawalPeriod" : [{ // A species specific time during which consumption of animal product is not appropriate
        "tissue" : { CodeableConcept }, // R!  Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
        "value" : { Quantity }, // R!  A value for the time
        "supportingInformation" : "<string>" // Extra information about the withdrawal period
      }]
    }]
  }]
}

@prefix fhir: <http://hl7.org/fhir/> .


[ a fhir:AdministrableProductDefinition;
  fhir:nodeRole fhir:treeRoot; # if this is the parser root

  # from Resource: .id, .meta, .implicitRules, and .language
  # from DomainResource: .text, .contained, .extension, and .modifierExtension
  fhir:AdministrableProductDefinition.identifier [ Identifier ], ... ; # 0..* An identifier for the pharmaceutical medicinal product
  fhir:AdministrableProductDefinition.subject [ Reference(MedicinalProductDefinition) ], ... ; # 0..* The product that this is a pharmaceutical product of
  fhir:AdministrableProductDefinition.administrableDoseForm [ CodeableConcept ]; # 1..1 The administrable dose form, after necessary reconstitution
  fhir:AdministrableProductDefinition.unitOfPresentation [ CodeableConcept ]; # 0..1 Todo
  fhir:AdministrableProductDefinition.producedFrom [ Reference(ManufacturedItemDefinition) ], ... ; # 0..* The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients
  fhir:AdministrableProductDefinition.ingredient [ Reference(Ingredient) ], ... ; # 0..* The ingredients of this administrable pharmaceutical product
  fhir:AdministrableProductDefinition.device [ Reference(DeviceDefinition) ], ... ; # 0..* Accompanying device
  fhir:AdministrableProductDefinition.characteristic [ # 0..* Characteristics e.g. a products onset of action
    fhir:AdministrableProductDefinition.characteristic.code [ CodeableConcept ]; # 1..1 A code expressing the type of characteristic
    # AdministrableProductDefinition.characteristic.value[x] : 0..1 A value for the characteristic. One of these 6
      fhir:AdministrableProductDefinition.characteristic.valueCoding [ Coding ]
      fhir:AdministrableProductDefinition.characteristic.valueQuantity [ Quantity ]
      fhir:AdministrableProductDefinition.characteristic.valueString [ string ]
      fhir:AdministrableProductDefinition.characteristic.valueDate [ date ]
      fhir:AdministrableProductDefinition.characteristic.valueBoolean [ boolean ]
      fhir:AdministrableProductDefinition.characteristic.valueAttachment [ Attachment ]
    fhir:AdministrableProductDefinition.characteristic.status [ CodeableConcept ]; # 0..1 The status of characteristic e.g. assigned or pending
  ], ...;
  fhir:AdministrableProductDefinition.routeOfAdministration [ # 1..* The path by which the pharmaceutical product is taken into or makes contact with the body
    fhir:AdministrableProductDefinition.routeOfAdministration.code [ CodeableConcept ]; # 1..1 Coded expression for the route
    fhir:AdministrableProductDefinition.routeOfAdministration.firstDose [ Quantity ]; # 0..1 The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
    fhir:AdministrableProductDefinition.routeOfAdministration.maxSingleDose [ Quantity ]; # 0..1 The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
    fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerDay [ Quantity ]; # 0..1 The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerTreatmentPeriod [ Ratio ]; # 0..1 The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.maxTreatmentPeriod [ Duration ]; # 0..1 The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies [ # 0..* A species for which this route applies
      fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.code [ CodeableConcept ]; # 1..1 Coded expression for the species
      fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod [ # 0..* A species specific time during which consumption of animal product is not appropriate
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue [ CodeableConcept ]; # 1..1 Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.value [ Quantity ]; # 1..1 A value for the time
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation [ string ]; # 0..1 Extra information about the withdrawal period
      ], ...;
    ], ...;
  ], ...;
]

This resource did not exist in Release 2

This analysis is available as XML or JSON.

<AdministrableProductDefinition xmlns="http://hl7.org/fhir"> 
 <!-- from Resource: id, meta, implicitRules, and language -->
 <!-- from DomainResource: text, contained, extension, and modifierExtension -->
 <identifier><!-- 0..* Identifier An identifier for the pharmaceutical medicinal product --></identifier>
 <subject><!-- 0..* Reference(MedicinalProductDefinition) The product that this is a pharmaceutical product of --></subject>
 <administrableDoseForm><!-- 1..1 CodeableConcept The administrable dose form, after necessary reconstitution --></administrableDoseForm>
 <unitOfPresentation><!-- 0..1 CodeableConcept Todo --></unitOfPresentation>
 <producedFrom><!-- 0..* Reference(ManufacturedItemDefinition) The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients --></producedFrom>
 <ingredient><!-- 0..* Reference(Ingredient) The ingredients of this administrable pharmaceutical product --></ingredient>
 <device><!-- 0..* Reference(DeviceDefinition) Accompanying device --></device>
 <characteristic>  <!-- 0..* Characteristics e.g. a products onset of action -->
  <code><!-- 1..1 CodeableConcept A code expressing the type of characteristic --></code>
  <value[x]><!-- 0..1 Coding|Quantity|string|date|boolean|Attachment A value for the characteristic --></value[x]>
  <status><!-- 0..1 CodeableConcept The status of characteristic e.g. assigned or pending --></status>
 </characteristic>
 <routeOfAdministration>  <!-- 1..* The path by which the pharmaceutical product is taken into or makes contact with the body -->
  <code><!-- 1..1 CodeableConcept Coded expression for the route --></code>
  <firstDose><!-- 0..1 Quantity The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement --></firstDose>
  <maxSingleDose><!-- 0..1 Quantity The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement --></maxSingleDose>
  <maxDosePerDay><!-- 0..1 Quantity The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerDay>
  <maxDosePerTreatmentPeriod><!-- 0..1 Ratio The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerTreatmentPeriod>
  <maxTreatmentPeriod><!-- 0..1 Duration The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation --></maxTreatmentPeriod>
  <targetSpecies>  <!-- 0..* A species for which this route applies -->
   <code><!-- 1..1 CodeableConcept Coded expression for the species --></code>
   <withdrawalPeriod>  <!-- 0..* A species specific time during which consumption of animal product is not appropriate -->
    <tissue><!-- 1..1 CodeableConcept Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk --></tissue>
    <value><!-- 1..1 Quantity A value for the time --></value>
    <supportingInformation value="[string]"/><!-- 0..1 Extra information about the withdrawal period -->
   </withdrawalPeriod>
  </targetSpecies>
 </routeOfAdministration>
</AdministrableProductDefinition>

{
  "resourceType" : "AdministrableProductDefinition",
  // from Resource: id, meta, implicitRules, and language
  // from DomainResource: text, contained, extension, and modifierExtension
  "identifier" : [{ Identifier }], // An identifier for the pharmaceutical medicinal product
  "subject" : [{ Reference(MedicinalProductDefinition) }], // The product that this is a pharmaceutical product of
  "administrableDoseForm" : { CodeableConcept }, // R!  The administrable dose form, after necessary reconstitution
  "unitOfPresentation" : { CodeableConcept }, // Todo
  "producedFrom" : [{ Reference(ManufacturedItemDefinition) }], // The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients
  "ingredient" : [{ Reference(Ingredient) }], // The ingredients of this administrable pharmaceutical product
  "device" : [{ Reference(DeviceDefinition) }], // Accompanying device
  "characteristic" : [{ // Characteristics e.g. a products onset of action
    "code" : { CodeableConcept }, // R!  A code expressing the type of characteristic
    // value[x]: A value for the characteristic. One of these 6:
    "valueCoding" : { Coding },
    "valueQuantity" : { Quantity },
    "valueString" : "<string>",
    "valueDate" : "<date>",
    "valueBoolean" : <boolean>,
    "valueAttachment" : { Attachment },
    "status" : { CodeableConcept } // The status of characteristic e.g. assigned or pending
  }],
  "routeOfAdministration" : [{ // R!  The path by which the pharmaceutical product is taken into or makes contact with the body
    "code" : { CodeableConcept }, // R!  Coded expression for the route
    "firstDose" : { Quantity }, // The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
    "maxSingleDose" : { Quantity }, // The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
    "maxDosePerDay" : { Quantity }, // The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
    "maxDosePerTreatmentPeriod" : { Ratio }, // The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
    "maxTreatmentPeriod" : { Duration }, // The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
    "targetSpecies" : [{ // A species for which this route applies
      "code" : { CodeableConcept }, // R!  Coded expression for the species
      "withdrawalPeriod" : [{ // A species specific time during which consumption of animal product is not appropriate
        "tissue" : { CodeableConcept }, // R!  Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
        "value" : { Quantity }, // R!  A value for the time
        "supportingInformation" : "<string>" // Extra information about the withdrawal period
      }]
    }]
  }]
}

@prefix fhir: <http://hl7.org/fhir/> .


[ a fhir:AdministrableProductDefinition;
  fhir:nodeRole fhir:treeRoot; # if this is the parser root

  # from Resource: .id, .meta, .implicitRules, and .language
  # from DomainResource: .text, .contained, .extension, and .modifierExtension
  fhir:AdministrableProductDefinition.identifier [ Identifier ], ... ; # 0..* An identifier for the pharmaceutical medicinal product
  fhir:AdministrableProductDefinition.subject [ Reference(MedicinalProductDefinition) ], ... ; # 0..* The product that this is a pharmaceutical product of
  fhir:AdministrableProductDefinition.administrableDoseForm [ CodeableConcept ]; # 1..1 The administrable dose form, after necessary reconstitution
  fhir:AdministrableProductDefinition.unitOfPresentation [ CodeableConcept ]; # 0..1 Todo
  fhir:AdministrableProductDefinition.producedFrom [ Reference(ManufacturedItemDefinition) ], ... ; # 0..* The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients
  fhir:AdministrableProductDefinition.ingredient [ Reference(Ingredient) ], ... ; # 0..* The ingredients of this administrable pharmaceutical product
  fhir:AdministrableProductDefinition.device [ Reference(DeviceDefinition) ], ... ; # 0..* Accompanying device
  fhir:AdministrableProductDefinition.characteristic [ # 0..* Characteristics e.g. a products onset of action
    fhir:AdministrableProductDefinition.characteristic.code [ CodeableConcept ]; # 1..1 A code expressing the type of characteristic
    # AdministrableProductDefinition.characteristic.value[x] : 0..1 A value for the characteristic. One of these 6
      fhir:AdministrableProductDefinition.characteristic.valueCoding [ Coding ]
      fhir:AdministrableProductDefinition.characteristic.valueQuantity [ Quantity ]
      fhir:AdministrableProductDefinition.characteristic.valueString [ string ]
      fhir:AdministrableProductDefinition.characteristic.valueDate [ date ]
      fhir:AdministrableProductDefinition.characteristic.valueBoolean [ boolean ]
      fhir:AdministrableProductDefinition.characteristic.valueAttachment [ Attachment ]
    fhir:AdministrableProductDefinition.characteristic.status [ CodeableConcept ]; # 0..1 The status of characteristic e.g. assigned or pending
  ], ...;
  fhir:AdministrableProductDefinition.routeOfAdministration [ # 1..* The path by which the pharmaceutical product is taken into or makes contact with the body
    fhir:AdministrableProductDefinition.routeOfAdministration.code [ CodeableConcept ]; # 1..1 Coded expression for the route
    fhir:AdministrableProductDefinition.routeOfAdministration.firstDose [ Quantity ]; # 0..1 The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
    fhir:AdministrableProductDefinition.routeOfAdministration.maxSingleDose [ Quantity ]; # 0..1 The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
    fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerDay [ Quantity ]; # 0..1 The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerTreatmentPeriod [ Ratio ]; # 0..1 The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.maxTreatmentPeriod [ Duration ]; # 0..1 The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
    fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies [ # 0..* A species for which this route applies
      fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.code [ CodeableConcept ]; # 1..1 Coded expression for the species
      fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod [ # 0..* A species specific time during which consumption of animal product is not appropriate
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue [ CodeableConcept ]; # 1..1 Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.value [ Quantity ]; # 1..1 A value for the time
        fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation [ string ]; # 0..1 Extra information about the withdrawal period
      ], ...;
    ], ...;
  ], ...;
]

This resource did not exist in Release 2

This analysis is available as XML or JSON.